AMW is a company operating in the pharmaceutical industry.
AMW as pharmaceutical company develops and manufactures improved medicines to optimize therapeutic outcomes and enhance patient well-being. With state-of-the-art production facilities in Germany, the entire pharmaceutical value chain is covered. Our mission is to provide patients and our partners with value-added medicines. Our biodegradable sustained-release drug delivery systems help improve medication adherence and allow for cost-effective therapies. Based on our technology platform, we build on a growing own and partnered development pipeline. We hereby cover the entire value chain, from (co-)development to manufacturing and commercialization or out-licensing. Based on our unparalleled expertise in formulation development, we support global as well as local pharma and biotech partners in developing and manufacturing high-quality products and life-cycle solutions. We have two approved products, goserelin and leuprorelin implants, which are distributed worldwide through both local and global pharma partners.
Company type
Products and services
Biopharmaceuticals, Finished Dosage Forms
Markets
Address
AMW, Birkerfeld 11, Warngau, Germany, 83627
